Get involved

Claim

Opening the claim…

Against a placebo stated to be inert, aluminium-adjuvanted vaccines (75,401 participants) have a risk ratio for any serious adverse event of 1.00 (95% CI 0.96 to 1.05) and for death of 1.01 (0.90 to 1.14), and mRNA vaccines (177,709 participants) of 1.03 (0.93 to 1.14) and 1.06 (0.83 to 1.35); across the 56 pre-specified kinds of trial and vaccine with an estimate for any serious adverse event, and the 53 with one for death, the number of risk-ratio intervals lying wholly above 1 is 0 and 0, and the number of risk-difference intervals lying wholly above zero is 1 and 0: in trials spanning children and adults the risk difference for any serious adverse event is +36.8 per 10,000 (+11.7 to +61.9) while the risk ratio is 1.15 (1.00 to 1.33). · sciencejournal.ai